|
|
|
Corporate Profile: Iconic Therapeutics
| Summary: |
Iconic Therapeutics is focused on therapeutic use of I-con1™ protein for the “wet” form of adult macular degeneration and many cancers. |
| Address (HQ): |
395 Oyster Point Boulevard
Suite 515
South San Francisco, CA 94080 |
| Phone #'s (HQ): |
| Main |
(650) 437-1000 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax #'s (HQ): |
| Main |
(650) 246-9011 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| email: |
| Main |
not known |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Financial
information: |
| not known |
| Internet
job postings: |
| not known |
| Number
of employees: |
| not known |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
